Background
Fungal endocarditis, a rare but severe infection of the cardiac valves,
is associated with significant morbidity and mortality. Recurrent aortic
valve fungal endocarditis is an even rarer clinical entity with limited
literature on management strategies. The condition is typically caused
by the spread of fungal spores through the bloodstream, which can occur
due to various factors, such as intravenous drug use, dental procedures,
or intravascular or intracardiac medical devices. Symptoms of aortic
valve fungal endocarditis may include fever, fatigue, shortness of
breath, chest pain, and a new or changing heart murmur. Diagnosis
typically involves a combination of blood tests, imaging studies, and
cardiac catheterization.